Analysis of chemical or biomolecular contents in a tiny amount of specimen presents a significant challenge in many biochemical studies and diagnostic applications. In this work, we present a single-layer, optofluidic device for real-time, high-throughput, quantitative analysis of droplet contents. Our device integrates an optical fiber-based, on-chip detection unit with a droplet-based microfluidic unit. It can quantitatively analyze the contents of individual droplets in real-time. It also achieves a detection throughput of 2000 droplets per second, a detection limit of 20 nM, and an excellent reproducibility in its detection results. In a proof-of-concept study, we demonstrate that our device can be used to perform detection of DNA and its mutations by monitoring the fluorescent signal changes of the target DNA/molecular beacon complex in single droplets. Our approach can be immediately extended to a real-time, high-throughput detection of other biomolecules (such as proteins and viruses) in droplets. With its advantages in throughput, functionality, cost, size, and reliability, the droplet-based optofluidic device presented here can be a valuable tool for many medical diagnostic applications.
Introduction
Droplet-based microfluidics presents great potential for conducting high-throughput chemical and biological assays due to its significant advantages in cost, screening time, and sensitivity. [1] [2] [3] [4] [5] [6] [7] This technology compartmentalizes reagents into aqueous-in-oil droplets with volumes ranging from femtoliters to nanoliters, as opposed to microliter sample volumes in conventional microfluidic methods. In addition, it allows the aqueous droplets to be separated by an oil phase, thus preventing undesirable contamination and cross-talk between neighboring droplets or between the reagents and channel walls. 2-3,5 Moreover, droplet microfluidics allows individual droplet production at kilohertz frequencies and makes it possible to conduct high-throughput assays of complex chemical, biochemical, or pharmaceutical analytical processes in a rapid, automated, and reproducible manner. 4 Recently, significant advances have been made in developing droplet microfluidics-based, highthroughput screening methods 8-10 for a variety of applications including drug discovery, directed enzyme evolution, bacteria screening, and nucleic acid analysis. 4,7,11-13 An effective, dropletbased, screening method will require the following three key functions: 1) encapsulation of materials in droplets, 2) manipulation (moving, splitting, sorting, etc.) of droplets, and 3) detection of products in droplets. 1 Thus far, significant progress has been made in realizing the first two functions: researchers have demonstrated encapsulation of various species including cells, microparticles, molecules, and DNA into individual droplets; 14-16 they have also achieved varieties of rapid droplet manipulation techniques in a controllable manner, including droplet transportation, fission, fusion, mixing, sorting, trapping, and packaging. [17] [18] [19] [20] [21] [22] [23] [24] [25] However, limited research has been conducted on developing techniques for rapid and sensitive detection and 4 analysis of droplet contents. 10, [26] [27] [28] [29] [30] In particular, to achieve rapid and quantitative measurements of fast-moving individual droplets often requires expensive instruments and/or sophisticated operation procedures. For example, although droplets can be observed and recorded by a fluorescence microscope equipped with a sensitive CCD camera, 4 regular CCD cameras fail in real-time detection of individual droplets moving at a high velocity and rely on detection of the average signal of many droplets. Thus, an expensive fast camera is required to capture data from a single fast-moving droplet. 31 Alternatively, confocal fluorescence microscopy has been used to quantify droplet contents in a high-throughput fashion. 32, 33 Using this method, high-throughput DNA assays have been achieved by characterizing a fluorescence resonance energy transfer (FRET) signal. 33 The dependence of the existing droplet-based detection methods on expensive
instruments (e.g., fast camera, confocal fluorescence microscope) prevents their widespread applications. We believe that an ideal droplet-based detection method should fulfill the following criteria: 1) low-cost fabrication with easy and automatic operation; 2) real-time and highthroughput individual droplet detection; 3) quantitative and sensitive characterization of droplet contents; and 4) excellent reproducibility.
Here we report an optofluidic [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] device for high-throughput, real-time, quantitative analysis of droplet contents. Our approach integrates an optical fiber-based detection unit with a dropletbased microfluidic device. By detecting the fluorescence intensity using photomultiplier tubes (PMTs), the contents of individual droplets were accurately analyzed in real-time with a highthroughput format (2000 droplets per second). While being significantly simpler and cheaper, our device can achieve an acceptable performance compared with previous methods, which require expensive equipment such as confocal or fluorescent microscopes coupled to a fast camera. 47 In addition, we demonstrate that our device can be used to detect DNA contents in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 5 droplets and perform single nucleotide polymorphism (SNP) analysis. SNP analysis is a major diagnostic method for genetic diseases, which is typically limited by sample consumption, nonspecific binding, and low reaction efficient in the conventional platform. 27 In this work, we demonstrate the detection of the abnormality on the BRCA1 gene which is known to cause breast and ovarian cancer.
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Experiments
Working mechanism. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 for DNA mutation detection, as summarized in Table 1 . The DNase water was purchased from Sigma-Aldrich.
Results and Discussion
Characterization 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 Here we test the detection throughput of our device. The throughput is majorly limited by the droplet generation process and flow speed. In the throughput-testing setup, the buffer inlet was blocked while the fluorescent solution and DI water were injected through Chem 1 and Chem 2 inlets, respectively. To achieve maximum throughput, the highest droplet production frequency and minimal inter-droplet distance were obtained by adjusting the respective flow rates of the fluorescent solution, DI water, and oil phase. The optimal flow condition of our device was obtained under these conditions: the oil phase had a flow rate of 1500 µl min -1 , and the total 9 combined flow rate of 1 µM fluorescent solution and DI water was fixed at 300 µl min -1 . The flow rate ratio between the 1 µM fluorescent solution and the DI water defines the concentration of fluorescence in each droplet, which could be varied from 0 M to 1 µM. By continuously increasing the flow rate of DI water from 0 µl min -1 to 300 µl min -1 , a concentration gradient of fluorescence was generated across several adjacent droplets. The resolution or "steepness" of the gradient was limited by the response time on the pumps in the system. The droplets were transported through 20 mm channel from the droplet generator to the detection region in around 20 ms, which is long enough to achieve uniform mixing. 27 As shown in the processed optical detection signal ( 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 analyses by sensing the fluorescence intensity of complexes of the molecular beacon and DNA in single droplets. The abnormality on BRCA1 gene, known to cause breast and ovarian cancer, was detected in this system. As summarized in Table 1, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 11 metal-ion solution in the buffer, which is consistent with the literarure. 50 Nevertheless, our device exhibits high sensitivity and demonstrates that the WT and SM can be distinguished. Our results also prove the robustness of the droplet-based optofluidic device for bioanalysis applications.
Next, we calculated the signal-to-noise ratio (SNR) as an indicator of detection capability of our device. The SNR is defined as , 
Conclusions
In summary, we have successfully developed a droplet-based optofluidic device for high- Moreover, we demonstrated that the device can detect single nucleotide mutations in DNA, making it an ideal platform for fast and cost-effective breast and ovarian cancer diagnosis.
This technique will be useful in many chemical, biochemical, and pharmaceutical analytical processes such as immunoassays and cancer diagnosis.
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